Table 1 Main characteristics of all screened patients
All patients | Without ineffective triggering | With ineffective triggering | ||||
|---|---|---|---|---|---|---|
All | Non refractory | Refractory | ||||
All | Included | |||||
Number (% of all patients) | 193 (100%) | 157 (81%) | 36 (19%) | 15 (8%) | 21 (11%) | 12 (6%) |
Age, years | 64 [54–72] | 65 [54–72] | 64 [59–71] | 65 [58–72] | 64 [60–71] | 63 [59–68] |
Sex ratio, M/F | 125/68 | 102/55 | 23/13 | 9/6 | 14/7 | 6/6 |
Weight, kg | 75 [66–94] | 75 [67–94] | 78 [60–94] | 79 [60–88] | 77 [61–105] | 83 [62–110] |
Size, cm | 170 [163–176] | 170 [163–176] | 171 [165–176] | 169 [164–177] | 172 [165–176] | 171 [164–175] |
BMI, kg/m2 | 26 [23–32] | 26 [23–32] | 25 [22–31] | 25 [23–28] | 25 [22–36] | 31 [22–36] |
COPD, n (%) | 20 (10%) | 14 (9%) | 6 (17%) | 2 (13%) | 4 (19%) | 3 (25%) |
Initial PSL, cmH2O | 10 [10–12] | 10 [10–12] | 14 [12–16]* | 14 [11–14] | 16 [13–18] | 17 [14–18] |
Optimized PSL, cmH2O | NA | NA | 12 [10–15] | 10 [8–13] | 14 [12–18]** | 17 [12–18] |
PEEP, cmH2O | 5 [5–7] | 5 [5–7] | 5 [5–8] | 5 [5–6] | 5 [5–8] | 7 [5–8] |
MV duration before screening, days | 4 [2–7] | 3 [2–7] | 4 [3–12] | 5 [2–12] | 4 [3–9] | 4 [3–7] |